Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants
Mary Lou Clements-Mann, Mamodikoe K. Makhene, Jacek Mrukowicz, Peter F. Wright, Yasutaka Hoshino, Karen Midthun, Ellen Sperber, Ruth Karron, Albert Z. Kapikian
Dive into the research topics of 'Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants'. Together they form a unique fingerprint.